Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GEN-003 maintenance in genital herpes
NCT03146403Phase 2Terminated
- Sponsor
- Genocea Biosciences
- Start
- May 2017
- Primary completion
- Dec 2017
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of GEN-003 in genital herpes, sponsored by Genocea Biosciences. Started May 2017; status: terminated.
02
Drugs
GEN-003
03
Conditions
genital herpes
Beyond the preview
Go deeper on NCT03146403.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03146403.